GeneoVax
吉诺卫
GeneoVax
Biotech/Healthcare
GenoVax (Shanghai) Biologics Co., Ltd. is committed to developing innovative vaccine technologies and products for respiratory infectious diseases.
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.